![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threate... Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. Show more
• First study of AllocetraTM in psoriatic arthritis, a chronic inflammatory condition that causes joint pain, swelling and stiffness, affects as many as 30% of people with psoriasis1, and has...
First patient dosed with AllocetraTM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of peopleThumb osteoarthritis currently has no...
Ness-Ziona, Israel, June 20, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company” or “Enlivex”), a clinical-stage macrophage reprogramming immunotherapy company, is...
Key Highlights Enrolled patients with severe knee osteoarthritis who were indicated for knee-replacement surgery received a single local injection of AllocetraTM into the knee as a “last...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -2.20588235294 | 1.36 | 1.46 | 1.23 | 48319 | 1.3948774 | CS |
4 | -0.07 | -5 | 1.4 | 1.48 | 1.23 | 38265 | 1.3834402 | CS |
12 | -0.3 | -18.4049079755 | 1.63 | 1.6648 | 1.18 | 61814 | 1.40646917 | CS |
26 | -1.57 | -54.1379310345 | 2.9 | 4.59 | 1.15 | 122955 | 2.20318075 | CS |
52 | -1.17 | -46.8 | 2.5 | 4.59 | 1.15 | 88739 | 2.28822446 | CS |
156 | -6.12 | -82.1476510067 | 7.45 | 13.95 | 1.15 | 86019 | 6.18769595 | CS |
260 | -20.57 | -93.9269406393 | 21.9 | 44.9 | 1.15 | 161595 | 9.64528786 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions